TickerFacts.

Neogen Corp (NEOG): Cost of Revenue

Annual figures by period end, from SEC filings.

$461.90M
Year ended 2026-05-31
+3.5%
3-year compound annual growth
+12.8%
5-year compound annual growth
+10.6%
10-year compound annual growth
$473.30M2011-05-31: $84.89M2012-05-31: $91.62M2013-05-31: $98.03M2014-05-31: $124.81M2015-05-31: $143.39M2016-05-31: $168.21M2017-05-31: $189.35M2018-05-31: $211.66M2019-05-31: $222.27M2020-05-31: $221.89M2021-05-31: $253.40M2022-05-31: $284.15M2023-05-31: $416.49M2024-05-31: $460.30M2025-05-31: $473.30M2026-05-31: $461.90M$461.90M
2011-05-31 Cost of Revenue (USD) 2026-05-31
Period endedCost of RevenueChange YoYSource filing
2026-05-31$461.90M-2.4%2026-07-30, From 2025-06-01
2025-05-31$473.30M+2.8%2026-07-30, From 2024-06-01
2024-05-31$460.30M+10.5%2026-07-30, From 2023-06-01
2023-05-31$416.49M+46.6%2025-07-30, From 2022-06-01
2022-05-31$284.15M+12.1%2024-07-30, From 2021-06-01
2021-05-31$253.40M+14.2%2023-08-15, From 2020-06-01
2020-05-31$221.89M-0.2%2022-07-27, From 2019-06-01
2019-05-31$222.27M+5.0%2021-07-30, From 2018-06-01
2018-05-31$211.66M+11.8%2020-07-30, From 2017-06-01
2017-05-31$189.35M+12.6%2019-07-30, From 2016-06-01
2016-05-31$168.21M+17.3%2018-07-27, From 2015-06-01
2015-05-31$143.39M+14.9%2017-07-28, From 2014-06-01
2014-05-31$124.81M+27.3%2016-07-29, From 2013-06-01
2013-05-31$98.03M+7.0%2015-07-30, From 2012-06-01
2012-05-31$91.62M+7.9%2014-07-30, From 2011-06-01
2011-05-31$84.89Mn/a2013-07-30, From 2010-06-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (In Vitro & In Vivo Diagnostic Substances), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
Neogen Corp (NEOG)2026-05-31$461.90M-2.4%
Myriad Genetics Inc (MYGN)2025-12-31$247.90M-1.7%
Lantheus Holdings, Inc. (LNTH)2025-12-31$599.66M+9.9%
Idexx Laboratories Inc (IDXX)2025-12-31$1.64B+8.3%
Alpha Teknova, Inc. (TKNO)2025-12-31$27.08M-11.3%
Immucell Corp (ICCC)2025-12-31$16.20M-12.7%
Aspira Women's Health Inc. (AWHL)2025-12-31$3.30M-10.9%
Anbio Biotechnology (NNNN)2025-12-31$1.10M-52.0%
Biomerica Inc (BMRA)2026-05-31$4.09M-15.0%

Compare NEOG, MYGN, LNTH, IDXX side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗